Real-world Leqembi study shows 82% of Alzheimer's patients stable
Go back to Real-world Leqembi study shows 82% of Alzheimer's patients stable| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 202.88 +5.14 (2.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $197.74 | 52 Week High | $333.65 | |||
| Open | $197.04 | 52 Week Low | $223.02 | |||
| Day High | $203.60 | P/E | 25.98 | |||
| Day Low | $196.92 | EPS | $7.81 | |||
| Volume | 227,769 | |||||

